Delivery Order SPE2DB20D3103-SPE2DB25FP8H9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $11,793.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $1,570.80. This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and no set-aside designation was used in the award. The contract represents a competitive procurement action within the pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a $18,761.49 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 14, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $7,441.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under firm fixed pricing. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $3,620.03 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages). This non-set-aside, firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is a child...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8H9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,763.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. This contract represents a continuation of the company's extensive role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal procurement portfolio demonstrates consistent competitive awards for pharmaceutical distribution across multiple therapeutic domains, positioning the company as a key vendor for federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 8/12/25 |